Mouse models for congenital disorders of glycosylation
- PMID: 21347588
- DOI: 10.1007/s10545-011-9295-7
Mouse models for congenital disorders of glycosylation
Abstract
Glycoprotein biosynthesis describes the process of co- and posttranslational attachment of sugar chains to proteins, a process that has been found in nearly all known organisms. Human deficiencies evoked by mutations in the glycosylation pathway of glycoproteins lead to congenital disorders of glycosylation (CDG), a rapidly expanding group of autosomal recessive inherited metabolic diseases with multisystemic phenotypes that are mostly combined with severe neurological impairment. Although investigations on new types of CDG have proceeded rapidly in recent years, the correlation between inaccurate protein glycosylation and pathological loss of functionality of distinct organ systems remains widely unknown, and therapeutics for the patients are mostly not available. Therefore, mouse models provide an outstanding helpful tool for investigations on different aspects of glycosylation deficiencies that cannot be performed in patients or cell culture. This review focuses on existing mouse models generated for the types of CDG that affect the N-glycosylation pathway.
Similar articles
-
A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2.Hum Mol Genet. 2016 Jun 1;25(11):2182-2193. doi: 10.1093/hmg/ddw085. Epub 2016 Apr 5. Hum Mol Genet. 2016. PMID: 27053713 Free PMC article.
-
Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype).J Inherit Metab Dis. 2007 Feb;30(1):107. doi: 10.1007/s10545-006-0486-6. Epub 2006 Dec 20. J Inherit Metab Dis. 2007. PMID: 17186415
-
Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model.Dis Model Mech. 2016 May 1;9(5):513-27. doi: 10.1242/dmm.022939. Epub 2016 Mar 3. Dis Model Mech. 2016. PMID: 26940433 Free PMC article.
-
[Congenital disorder of glycosylation type Ia (CDG Ia) - underdiagnosed entity?].Duodecim. 2016;132(3):253-9. Duodecim. 2016. PMID: 26951030 Review. Finnish.
-
Congenital disorders of glycosylation. Part I. Defects of protein N-glycosylation.Acta Biochim Pol. 2013;60(2):151-61. Epub 2013 May 31. Acta Biochim Pol. 2013. PMID: 23730680 Review.
Cited by
-
GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges.Neurotherapeutics. 2018 Oct;15(4):900-914. doi: 10.1007/s13311-018-0671-y. Neurotherapeutics. 2018. PMID: 30338442 Free PMC article. Review.
-
DPAGT1-CDG: Report of Two New Pediatric Patients and Brief Review of the Literature.Mol Syndromol. 2023 Aug;14(4):322-330. doi: 10.1159/000529494. Epub 2023 Mar 8. Mol Syndromol. 2023. PMID: 37766827 Free PMC article.
-
Arabidopsis thaliana alpha1,2-glucosyltransferase (ALG10) is required for efficient N-glycosylation and leaf growth.Plant J. 2011 Oct;68(2):314-25. doi: 10.1111/j.1365-313X.2011.04688.x. Epub 2011 Jul 27. Plant J. 2011. PMID: 21707802 Free PMC article.
-
Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.Mol Genet Metab. 2024 Aug;142(4):108513. doi: 10.1016/j.ymgme.2024.108513. Epub 2024 Jun 13. Mol Genet Metab. 2024. PMID: 38917675 Free PMC article.
-
Lack of phosphomannomutase 2 affects Xenopus laevis morphogenesis and the non-canonical Wnt5a/Ror2 signalling.J Inherit Metab Dis. 2015 Nov;38(6):1137-46. doi: 10.1007/s10545-015-9874-0. Epub 2015 Jul 4. J Inherit Metab Dis. 2015. PMID: 26141167
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources